TLIS 2-DAY DEADLINE ALERT: Hagens Berman, National Trial
SAN FRANCISCO, March 06, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Talis Biomedical Corporation (NASDAQ: TLIS) investors with significant losses to...
Stay updated with breaking news from Lis Stock. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAN FRANCISCO, March 06, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Talis Biomedical Corporation (NASDAQ: TLIS) investors with significant losses to...
SAN FRANCISCO, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Talis Biomedical Corporation (NASDAQ: TLIS) investors with significant losses to...
SAN FRANCISCO, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Talis Biomedical Corporation (NASDAQ: TLIS) investors with significant losses to...
SAN FRANCISCO, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Talis Biomedical Corporation (NASDAQ: TLIS) investors with significant losses to...
In last trading session, Talis Biomedical Corporation (NASDAQ:TLIS) saw 0.34 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $4.66 trading at $0.06 or 1.30% at ring of the bell on the day assigns it a market valuation of $124.14M. That c